Cargando…
Are the Allergic Reactions of COVID-19 Vaccines Caused by mRNA Constructs or Nanocarriers? Immunological Insights
The Food and Drug Administration (FDA) has recently authorized the two messenger RNA (mRNA) vaccines BNT162b2 and mRNA-1273 for emergency use against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing the COVID-19 coronavirus disease. BNT162b2 and mRNA-1273 vaccines were develo...
Autores principales: | Selvaraj, Gurudeeban, Kaliamurthi, Satyavani, Peslherbe, Gilles H., Wei, Dong-Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140554/ https://www.ncbi.nlm.nih.gov/pubmed/34021862 http://dx.doi.org/10.1007/s12539-021-00438-3 |
Ejemplares similares
-
Identifying potential drug targets and candidate drugs for COVID-19: biological networks and structural modeling approaches
por: Selvaraj, Gurudeeban, et al.
Publicado: (2021) -
Structure-Based Virtual Screening Reveals Ibrutinib and Zanubrutinib as Potential Repurposed Drugs against COVID-19
por: Kaliamurthi, Satyavani, et al.
Publicado: (2021) -
Circulating miR-1246 Targeting UBE2C, TNNI3, TRAIP, UCHL1 Genes and Key Pathways as a Potential Biomarker for Lung Adenocarcinoma: Integrated Biological Network Analysis
por: Huang, Siyuan, et al.
Publicado: (2020) -
Designing of CD8(+) and CD8(+)-overlapped CD4(+) epitope vaccine by targeting late and early proteins of human papillomavirus
por: Kaliamurthi, Satyavani, et al.
Publicado: (2018) -
Integrated PPI- and WGCNA-Retrieval of Hub Gene Signatures Shared Between Barrett's Esophagus and Esophageal Adenocarcinoma
por: Nangraj, Asma Sindhoo, et al.
Publicado: (2020)